{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:07Z","timestamp":1786116787060,"version":"build-2736575974"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.05.003","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:49:48Z","timestamp":1781725788000},"page":"727-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury"],"prefix":"10.1016","volume":"53","author":[{"given":"Melanie A.","family":"McNally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet S.","family":"Soul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.earlhumdev.2010.05.010","article-title":"Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy","volume":"86","author":"Kurinczuk","year":"2010","journal-title":"Early Hum Dev"},{"issue":"14","key":"10.1016\/j.clp.2026.05.003_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","article-title":"Moderate hypothermia to treat perinatal asphyxial encephalopathy","volume":"361","author":"Azzopardi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.05.003_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2020.04.016","article-title":"Neuroprotection care bundle implementation to decrease acute brain injury in preterm infants","volume":"110","author":"Murthy","year":"2020","journal-title":"Pediatr Neurol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.003_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1474-4422(11)70016-3","article-title":"Treatment advances in neonatal neuroprotection and neurointensive care","volume":"10","author":"Johnston","year":"2011","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.clp.2026.05.003_bib5","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1007\/s12035-024-03915-0","article-title":"Significance of melatonin in the regulation of circadian rhythms and disease management","volume":"61","author":"Megha","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"11","key":"10.1016\/j.clp.2026.05.003_bib6","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.3390\/ijms22115481","article-title":"Melatonin for neonatal encephalopathy: from bench to bedside","volume":"22","author":"Pang","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib7","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1038\/s41598-023-36653-9","article-title":"Comparing the efficacy in reducing brain injury of different neuroprotective agents following neonatal hypoxia\u2013ischemia in newborn rats: a multi-drug randomized controlled screening trial","volume":"13","author":"Sabir","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2014.186","article-title":"Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study","volume":"35","author":"Aly","year":"2015","journal-title":"J Perinatol"},{"issue":"7","key":"10.1016\/j.clp.2026.05.003_bib9","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41390-024-03742-y","article-title":"Pro-inflammatory biomarkers and long-term neurological outcomes in hypothermia plus melatonin treated asphyxiated newborns","volume":"97","author":"Jerez-Calero","year":"2025","journal-title":"Pediatr Res"},{"issue":"7","key":"10.1016\/j.clp.2026.05.003_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/PCC.0000000000002346","article-title":"Hypothermia plus melatonin in asphyctic newborns: a randomized-controlled pilot study","volume":"21","author":"Jerez-Calero","year":"2020","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"10.1016\/j.clp.2026.05.003_bib11","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1038\/s41390-025-03876-7","article-title":"Melatonin: a positive influencer of inflammation in neonatal encephalopathy","volume":"97","author":"Pang","year":"2025","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028243","article-title":"Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction","volume":"9","author":"Palmer","year":"2019","journal-title":"BMJ Open"},{"issue":"s1","key":"10.1016\/j.clp.2026.05.003_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.clp.2026.05.003_bib14","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1111\/epi.18563","article-title":"Topiramate for the treatment of neonatal seizures and beyond","volume":"66","author":"L\u00f6scher","year":"2025","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jpeds.2010.04.019","article-title":"Oral topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia: a safety study","volume":"157","author":"Filippi","year":"2010","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.clp.2026.05.003_bib16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/14767058.2017.1304536","article-title":"Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI): a feasibility study","volume":"31","author":"Filippi","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000499084","article-title":"Topiramate plus cooling for hypoxic-ischemic encephalopathy: a randomized, controlled, multicenter, double-blinded trial","volume":"116","author":"Nu\u00f1ez-Ramiro","year":"2019","journal-title":"Neonatology"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000484891","article-title":"Magnesium as a neuroprotective agent: a review of its use in the fetus, term infant with neonatal encephalopathy, and the adult stroke patient","volume":"40","author":"Lingam","year":"2018","journal-title":"Dev Neurosci"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41390-019-0539-9","article-title":"Magnesium sulfate: a last roll of the dice for anti-excitotoxicity?","volume":"86","author":"Galinsky","year":"2019","journal-title":"Pediatr Res"},{"issue":"9","key":"10.1016\/j.clp.2026.05.003_bib20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/dmcn.15899","article-title":"Neonatal magnesium sulphate for neuroprotection: a systematic review and meta-analysis","volume":"66","author":"Shepherd","year":"2024","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib21","first-page":"1","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","volume":"1968","author":"Doyle","year":"2009","journal-title":"Cochrane Libr"},{"issue":"10","key":"10.1016\/j.clp.2026.05.003_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002398","article-title":"Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.clp.2026.05.003_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/OGX.0000000000000778","article-title":"Antenatal corticosteroids and magnesium sulfate for improved preterm neonatal outcomes: a review of guidelines","volume":"75","author":"Tsakiridis","year":"2020","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.clp.2026.05.003_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/ijms18020265","article-title":"Role of antioxidants in neonatal hypoxic\u2013ischemic brain injury: new therapeutic approaches","volume":"18","author":"Arteaga","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clp.2026.05.003_bib25","first-page":"405","article-title":"Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats","volume":"33","author":"Palmer","year":"1993","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.clp.2026.05.003_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1542\/peds.101.2.185","article-title":"Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity","volume":"101","author":"Van Bel","year":"1998","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib27","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/adc.2005.086652","article-title":"Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia","volume":"91","author":"Benders","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pediatrneurol.2006.08.005","article-title":"Effect of allopurinol supplementation on nitric oxide levels in asphyxiated newborns","volume":"36","author":"Gunes","year":"2007","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib29","doi-asserted-by":"crossref","first-page":"F162","DOI":"10.1136\/archdischild-2011-300356","article-title":"Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials","volume":"97","author":"Kaandorp","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib30","doi-asserted-by":"crossref","first-page":"F216","DOI":"10.1136\/archdischild-2014-306769","article-title":"Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo-controlled trial","volume":"100","author":"Kaandorp","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12887-019-1566-8","volume":"19","author":"Maiwald","year":"2019","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.clp.2026.05.003_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pediatrneurol.2018.02.009","article-title":"Xenon combined with hypothermia in perinatal hypoxic-ischemic encephalopathy: a noble gas, a noble mission","volume":"84","author":"Amer","year":"2018","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.clp.2026.05.003_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1542\/peds.2013-0787","article-title":"Xenon ventilation during therapeutic hypothermia in neonatal encephalopathy: a feasibility study","volume":"133","author":"Dingley","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clp.2026.05.003_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial","volume":"15","author":"Azzopardi","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clp.2026.05.003_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ebiom.2019.08.034","article-title":"Prospective qualification of early cerebral biomarkers in a randomised trial of treatment with xenon combined with moderate hypothermia after birth asphyxia","volume":"47","author":"Azzopardi","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.clp.2026.05.003_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pediatrneurol.2014.06.008","article-title":"Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection","volume":"51","author":"Rangarajan","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab172","article-title":"Recombinant erythropoietin does not augment hypothermic white matter protection after global cerebral ischaemia in near-term fetal sheep","volume":"3","author":"Wassink","year":"2021","journal-title":"Brain Commun"},{"issue":"15","key":"10.1016\/j.clp.2026.05.003_bib38","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3109\/14767058.2013.789846","article-title":"Neuroprotective effects of hypothermia and erythropoietin after perinatal asphyxia in newborn rats","volume":"26","author":"Spasojevic","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib39","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clp.2026.05.003_bib40","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1542\/peds.2008-3553","article-title":"Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy","volume":"124","author":"Zhu","year":"2009","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2026.05.003_bib41","doi-asserted-by":"crossref","first-page":"e1135","DOI":"10.1542\/peds.2009-2268","article-title":"Human recombinant erythropoietin in asphyxia neonatorum: pilot trial","volume":"125","author":"Elmahdy","year":"2010","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.clp.2026.05.003_bib42","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/jp.2017.17","article-title":"Erythropoietin monotherapy in perinatal asphyxia with moderate to severe encephalopathy: a randomized placebo-controlled trial","volume":"37","author":"Malla","year":"2017","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.003_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1542\/peds.2012-0498","article-title":"Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics","volume":"130","author":"Wu","year":"2012","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib44","doi-asserted-by":"crossref","first-page":"e20160191","DOI":"10.1542\/peds.2016-0191","article-title":"High-dose erythropoietin and hypothermia for hypoxic-ischemic encephalopathy: a phase II trial","volume":"137","author":"Wu","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2026.05.003_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000486820","article-title":"High-dose erythropoietin for asphyxia and encephalopathy (HEAL): a randomized controlled trial \u2013 background, aims, and study protocol","volume":"98195","author":"Juul","year":"2018","journal-title":"Neonatology"},{"issue":"2","key":"10.1016\/j.clp.2026.05.003_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa2119660","article-title":"Trial of erythropoietin for hypoxic\u2013ischemic encephalopathy in newborns","volume":"387","author":"Wu","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/pr.2015.101","article-title":"Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial","volume":"78","author":"Baserga","year":"2017","journal-title":"Pediatr Res"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41372-021-01081-y","article-title":"Darbepoetin as a neuroprotective agent in mild neonatal encephalopathy: a randomized, placebo-controlled, feasibility trial","volume":"41","author":"DuPont","year":"2021","journal-title":"J Perinatol"},{"issue":"4","key":"10.1016\/j.clp.2026.05.003_bib49","doi-asserted-by":"crossref","first-page":"e681","DOI":"10.1542\/peds.2008-2701","article-title":"Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants","volume":"124","author":"Brown","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.clp.2026.05.003_bib50","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1542\/peds.2007-2711","article-title":"A phase I\/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety","volume":"122","author":"Juul","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ana.24677","article-title":"Recombinant human erythropoietin improves neurological outcomes in very preterm infants","volume":"80","author":"Song","year":"2016","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1542\/peds.2013-4307","article-title":"Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo","volume":"133","author":"Ohls","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2026.05.003_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A randomized trial of erythropoietin for neuroprotection in preterm infants","volume":"382","author":"Juul","year":"2020","journal-title":"New Eng J Med"},{"issue":"8","key":"10.1016\/j.clp.2026.05.003_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamapediatrics.2025.0807","article-title":"Darbepoetin, red cell mass, and neuroprotection in preterm infants: a randomized clinical trial","volume":"179","author":"Ohls","year":"2025","journal-title":"JAMA Pediatr"},{"issue":"1\u20132","key":"10.1016\/j.clp.2026.05.003_bib55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/pr.2017.243","article-title":"Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells","volume":"83","author":"Wagenaar","year":"2018","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41390-021-01716-y","article-title":"Combined hypothermia and mesenchymal stem cells in animal models of neonatal hypoxic\u2013ischaemic encephalopathy: a systematic review","volume":"92","author":"Teo","year":"2022","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/096368916X692861","article-title":"Pivotal role of brain-derived neurotrophic factor secreted by mesenchymal stem cells in severe intraventricular hemorrhage in newborn rats","volume":"26","author":"Ahn","year":"2017","journal-title":"Cell Transplant"},{"issue":"5","key":"10.1016\/j.clp.2026.05.003_bib58","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.3390\/ijms25052879","article-title":"A review of the use of extracellular vesicles in the treatment of neonatal diseases: current state and problems with translation to the clinic","volume":"25","author":"Goryunov","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clp.2026.05.003_bib59","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1038\/s41598-020-61311-9","article-title":"Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety","volume":"10","author":"Tsuji","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib60","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/stcltm\/szad027","article-title":"A pilot phase I trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic-ischemic encephalopathy","volume":"12","author":"Cotten","year":"2023","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"10.1016\/j.clp.2026.05.003_bib61","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","article-title":"Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study","volume":"21","author":"Baak","year":"2022","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.clp.2026.05.003_bib62","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/STROKEAHA.125.050786","article-title":"PASSIoN trial: 2-Year safety and neurodevelopment","volume":"56","author":"Wagenaar","year":"2025","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.clp.2026.05.003_bib63","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/sctm.17-0219","article-title":"Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial","volume":"7","author":"Ahn","year":"2018","journal-title":"Stem Cells Transl Med"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:14:20Z","timestamp":1786018460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000515"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.003","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugs and Cell-Based Therapies for the Prevention and Treatment of Neonatal Brain Injury","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}